CCClaudia Adriana Colín-Castro

Claudia Adriana Colín-Castro

*This is an algorithmically generated author record based on publicly available information.

Claudia Adriana Colín-Castro has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Azole Resistance in Candida parapsilosis From Patients With Burns in Mexico: A Genomic and Phylogenetic Analysis

    by María de Lourdes García‐Hernández, Luis Ángel Nuñez‐García, Jossue Ortíz‐Álvarez, Marco Antonio Delaye‐Martínez, Marlen Flores‐Huacuja, María del Rocío Vazquez‐Olivares, Luis Fernando Espinosa‐Camacho, Gabriela Delgado‐Sapien, María del Rosario Morales‐Espinosa, Noé Becerra‐Lobato, et al.

    Background: Candida species are common causes of nosocomial infections. Candida parapsilosis has emerged as an important pathogen . Mortality rates associated with invasive C. parapsilosis infections range from 14.5% to 47%, with azole resistance estimated between 4% and 15%. Resistance mechanisms include mutations in ERG11 that diminish azole binding, upregulation of ergosterol biosynthesis genes due to mutations in regulatory factors like UPC2 and NDT80 , and increased efflux pump activity. Methods: Thirty clinical strains of the C. parapsilosis complex were isolated from bloodstream cultures, biopsies and catheter tips from hospitalised patients from a major rehabilitation centre in Mexico between June 2011 and August 2016. Minimum inhibitory concentrations for fluconazole, voriconazole, itraconazole, caspofungin, micafungin, anidulafungin and amphotericin B were determined using the broth microdilution method. Whole genome sequencing was conducted using Illumina technology, with subsequent assembly and annotation. Analyses included antifungal resistance variant screening, SNP distance, average nucleotide identity and phylogenetic comparisons with publicly available genomes. Results: Most strains (96.7%, 29/30) were identified as C. parapsilosis sensu stricto, predominantly isolated from blood. Thirty‐three percent of isolates showed phenotypic resistance to fluconazole. The SNP‐distance and maximum‐likelihood phylogenetic analyses revealed two distinct haplotypes and the genotype 1: ERG11 WT/Y132F , CDR1 I1287V/I1287V and UPC2 WT/N455D was the most represented (8/10 isolates). Conclusions: C. parapsilosis sensu stricto was the predominant species isolated, with a notable proportion exhibiting resistance to FLU and VOR. The Y132F variant in the ERG11 gene was present in most sequenced isolates.

  • Unusual encounter: Isolation of Carnobacterium divergens in an immunocompetent patient with a meat grinder Injury. Case report

    by Corazón Barrientos-Flores, María de Lourdes García-Hernández, Braulio Josué Mendez-Sotelo, Melissa HernánDez-Durán, Guillermo Cerón-González, Rafael Franco-Cendejas, Claudia A. Colín-Castro, Luis Esaú LópEz-JácOme

    The genus Carnobacterium belongs to lactic acid bacteria, this group are composed by 12 species. These microorganisms are associated with mucosal surface, present in food-related habitats including plant, wine, milk, and meat environments. In humans, evidence of Carnobacterium spp., about the disease spectrum remains unknown. Current work is about a 25-year-old male, was admitted to the emergency room for transmetacarpal traumatic amputation of his left hand caused by a meat grinder. In deep soft tissue samples obtained from surgery, Carnobacterium divergens was isolated. He was treated with piperacillin-tazobactam and was switched to amoxicillin-clavulanate for five more days with clinical success. Written informed consent was obtained from the participating patient for publication of this case report and any accompanying images. Therefore, the pathogenic role of Carnobacterium spp., remains unknown and classically is not considered pathogenic to humans. However, in previous cases where was associated with infection, the described outcomes were good. The misidentification showed that conventional identification methods are not accurate.

  • Open Access

    Polymicrobial Osteomyelitis in a Patient With Isolation of Trueperella bernardiae : A Case Report and Literature Review

    by Marco Antonio Delaye-Martínez, Edgar Samuel Vanegas-Rodríguez, Braulio Mendez-Sotelo, María de Lourdes García-Hernández, Claudia Adriana Colín-Castro, Rafael Franco-Cendejas, Luis Esaú López-Jácome

    Background: Trueperella bernardiae is a Gram‐positive rod that has been described as an opportunistic pathogen in immunocompromised patients. In a significant number of documented cases, infections with Trueperella bernardiae have been associated with polymicrobial infections, which highlight the fact that important bacteria–bacteria relations might be involved in the natural course of these infections, especially in patients with chronic disease courses and a history of multiple antibiotic treatments. Case Presentation: We present a case of a 24‐year‐old woman with a 3‐year history of a chronic pressure ulcer on the right foot associated with varus and cavus deformity. As per relevant medical history, she was positive for multiple wound healing sessions with wound debridement and a large number of antibiotic treatments with minimal improvement. Microbiological cultures were taken from the wound, and a soft tissue infection diagnosis was initially made. Empirical treatment was initiated with levofloxacin. At 48 h, cultures were positive for Providencia stuartii, Pseudomonas aeruginosa, Proteus penneri, Streptococcus agalactiae , and Trueperella bernardiae , and the susceptibility test was performed. Three weeks later, the symptoms progressed to purulent exudate of the wound and foul‐smelling with the positive probe‐to‐bone test. Diagnosis was changed to polymicrobial osteomyelitis, and antibiotic therapy with ciprofloxacin and trimethoprim‐sulfamethoxazole was prescribed for a 4‐week course of treatment, achieving the complete remission of symptoms. Conclusions: Trueperella bernardiae represents an emerging bacterium that can be isolated in various clinical presentations. On osteoarticular infections, the presence of comorbidities, mobility limitations, and a history of multiple antibiotic treatments may be determinant. Their isolation as part of polymicrobial infections highlights relevant interspecies interactions. Research is still lacking in determining standardized methodologies for susceptibility testing and specific clinical breakpoints to guide clinical decisions.

  • Open Access

    In vitro activity of ceftazidime/avibactam, cefiderocol, meropenem/vaborbactam and imipenem/relebactam against clinical strains of the Stenotrophomonas maltophilia complex

    by Braulio Josué Méndez-Sotelo, Mónica Delgado-Beltrán, Melissa Hernández-Durán, Claudia Adriana Colín-Castro, José Esquivel-Bautista, Sandra Angélica Ortega-Oliva, Jossue Ortiz-Álvarez, Rodolfo García-Contreras, Rafael Franco-Cendejas, Luis Esau Lopez Jacome

    Background: Infections caused by Stenotrophomonas maltophilia and related species are increasing worldwide. Unfortunately, treatment options are limited, whereas the antimicrobial resistance is increasing. Methods: We included clinical isolates identified as S. maltophilia by VITEK 2 Compact. Ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam, cefiderocol, quinolones, and tetracycline family members were evaluated by broth microdilution method and compared with first-line treatment drugs. Minimum inhibitory concentrations (MICs) were reported for all antibiotics. We sequenced the Whole Genome of cefiderocol resistant strains (CRSs) and annotated their genes associated with cefiderocol resistance (GACR). Presumptive phylogenetic identification employing the 16S marker was performed. Results: One hundred and one clinical strains were evaluated, sulfamethoxazole and trimethoprim, levofloxacin and minocycline showed susceptibilities of 99.01%, 95.04% and 100% respectively. Ceftazidime was the antibiotic with the highest percentage of resistance in all samples (77.22%). Five strains were resistant to cefiderocol exhibiting MIC values ≥ 2 μg/mL (4.95%). The β-lactamase inhibitors meropenem/vaborbactam and imipenem/relebactam, failed to inhibit S. maltophilia, preserving both MIC50 and MIC90 ≥64 μg/mL. Ceftazidime/avibactam restored the activity of ceftazidime decreasing the MIC range. Tigecycline had the lowest MIC range, MIC50 and MIC90. Phylogeny based on 16S rRNA allowed to identify to cefiderocol resistant strains as putative species clustered into Stenotrophomonas maltophilia complex (Smc). In these strains, we detected GARCs such as Mutiple Drug Resistance (MDR) efflux pumps, L1-type β-lactamases, iron transporters and type-1 fimbriae. Conclusion: Antimicrobial resistance to first-line treatment is low. The in vitro activity of new β-lactamase inhibitors against S. maltophilia is poor, but avibactam may be a potential option. Cefiderocol could be considered as a potential new option for multidrug resistant infections. Tetracyclines had the best in vitro activity of all antibiotics evaluated.


  • Association of TLR4 gene polymorphisms with sepsis after a burn injury: findings of the functional role of rs2737190 SNP

    by Claudia A. Colín-Castro, Rafael Franco-Cendejas, Hector I. Rocha-González, Esteban Cruz-Arenas, Norberto Leyva-García, Roberto Sánchez-Sánchez, Gerardo Leyva-Gomez, Rocío Gómez, Balam Muñoz, Hernán Cortés, et al.

    Sepsis is a life-threatening organ dysfunction condition caused by a dysregulated response to an infection that is common among patients with moderate to severe burn injury. Previously, genomic variants in Toll-like receptor 4 (TLR4), a key innate immunity receptor, have been associated with sepsis and infection susceptibility. In this study, the association of six TLR4 SNPs with sepsis after burn injury was tested in the Mexican mestizo population. We found that the rs2737190 polymorphism is associated with sepsis after burn trauma. Interestingly, the G allele and GG genotype were associated with a lower risk of developing sepsis. Since the rs2737190 SNP is in the promoter region of the TLR4 gene, we analyzed the possibility that this polymorphism regulates the TLR4 pathway. We cultured peripheral blood mononuclear cells from different genotype carriers and found, after stimulation with LPS, that carriers of the GG genotype showed a higher expression of TLR4, IL6, and TNFα than AA genotype carriers. The results suggest that the GG genotype produces an increase in the TLR4 expression, and therefore an improvement in the immune response. We conclude that the rs2737190 polymorphism may become a useful marker for genetic studies of sepsis in patients after a burn injury.


  • Open Access

    Serological prevalence of SARS-CoV-2 infection and associated factors in healthcare workers in a “non-COVID” hospital in Mexico City

    by Esteban Cruz-Arenas, Elizabeth Cabrera-Ruiz, Sara Laguna-Barcenas, Claudia A. Colin-Castro, Tatiana Chavez, Rafael Franco-Cendejas, Clemente Ibarra, Javier Perez-Orive

    In spite of high mortality from COVID-19, in Mexico the number of confirmed cases and diagnostic tests per million population are lower than for other comparable countries, which leads to uncertainty about the actual extent of the pandemic. In Mexico City, healthcare workers represent an important fraction of individuals with SARS-CoV-2 infection. This work aims to estimate the frequency of antibodies to SARS-CoV-2 and identify associated factors in healthcare workers at a large hospital in Mexico City. We conducted a serological survey in a non-COVID national referral teaching hospital. We selected a representative sample of 300 individuals. Blood samples were collected and questionnaires were applied between August 10 th and September 9 th , 2020. ELISA results indicate a serological prevalence of SARS-CoV-2 infection of 13.0%. Working in the janitorial and security groups, having an educational level below a university degree, and living with a larger number of people, were also identified as sociodemographic factors that increase the risk of having SARS-CoV-2 infection. Thus, less favored socioeconomic groups are at significantly higher risk of experiencing SARS-CoV-2 infection. Even in healthcare workers there is still a majority of individuals that are seronegative, and thus the risk of continued epidemic waves and mortality remains high.